Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Lippo Karawaci Tbk. (LPKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Lippo Karawaci Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Lippo Karawaci Tbk. trades at Rp60 (market cap 4.25T, 112.03M 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 13.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (112.03M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | LPKR | |
|---|---|---|
Market Cap | 310.75B | 4.25T |
Volume | 963.6K | 112.03M |
Lot | 9.64K | 1.12M |
Turnover | 217.67M | 6.81B |
Average Price | 225.89 | 60.76 |
Value | 217.67M | 6.81B |
Indicative Equilibrium Price | 226 | 60 |
Indicative Equilibrium Volume | 1K | 44.54K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Lippo Karawaci Tbk.
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →
